[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.236.145.124. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 418
Citations 0
Comment & Response
February 16, 2016

Pharmacy Expenditures for Children With Serious Chronic Illness

Author Affiliations
  • 1Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City
 

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2016;315(7):706. doi:10.1001/jama.2015.16978

To the Editor Ms Swenson and colleagues1 reported findings from a retrospective analysis of the California Children’s Services paid claims data set for children with chronic illness. Their data illustrate the need for clinical, economic, and quality outcomes in patients with hemophilia. The authors seemed surprised by the fact that 0.4% of the cohort received 1 class of medications (antihemophilic factor) and accounted for 40.9% of total pharmacy expenditures.

×